Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment: HABIT
Sponsor: |
National Institutes of Health |
Enrolling: |
Male and Female Patients |
Study Length: |
6 Months |
IRB Number: |
AAAJ7350 |
U.S. Govt. ID: |
NCT02029742 |
Contact: |
Nancy Green: 212-305-0494 / nsg11@columbia.edu |
The purpose of this research is to learn how to help parent youth pairs work together to help youth with sickle cell disease take hydroxyurea every day as a daily habit. This study is for children and teens ages 10-18 with Sickle Cell Anemia taking hydroxyurea, and their parents (or guardians). Many children and teens do not use hydroxyurea every day. Daily use of hydroxyurea can help it work better to improve health. Taking it every day would be a healthy habit. This study, will evaluate whether those methods are useful for learning to take hydroxyurea every day.
This study is closed
Investigator
Nancy Green, MD
Is your child currently prescribed hydroxyurea? |
Yes |
No |
Is your child able to speak/read English or Spanish? |
Yes |
No |
Does your child have Sickle type - homozygous sickle disease or sickle-beta thalassemia disease? |
Yes |
No |